Chongqing Pharscin Pharmaceutical News

Watson Pharmaceuticals: Announcement on the approval of Liuwei Anshen capsules as the country\'s first grade 2 protected variety of traditional Chinese medicine

Sep 26 12:00 ET

Watson Pharmaceuticals: Announcement on changes in the company\'s drug production license

Sep 25 12:00 ET

Watson Pharmaceuticals: Announcement on the company\'s receipt of government subsidies

Sep 24 12:00 ET

Watson Pharmaceuticals: Notice on receipt of approval letter for drug re-registration

Sep 9 12:00 ET

Watson Pharmaceuticals: Announcement on the approval of licorice and plum tablets for registration in Singapore

Sep 6 12:00 ET

Watson Pharmaceuticals: 2024 Semi-Annual Equity Distribution Implementation Notice

Sep 3 12:00 ET

Watson Pharmaceuticals: 2024 Semi-Annual Results Online Briefing Investor Relations Activity Record Form

Aug 27 03:50 ET

Chongqing Pharscin Pharmaceutical: Announcement Regarding Profit Distribution Plan for H1 2024.

Aug 21 12:00 ET

Chongqing Pharscin Pharmaceutical: Notice Regarding the Online Mid-Year Performance Briefing for 2024

Aug 21 12:00 ET

Chongqing Pharscin Pharmaceutical: Announcement on the Action Plan for Double Improvement of Quality and Profit

Aug 21 12:00 ET

Chongqing Pharscin Pharmaceutical: Regulations on information disclosure (August 2024)

Aug 21 12:00 ET

Chongqing Pharscin Pharmaceutical: Announcement of the resolution of the Supervisory Board on the semi-annual report.

Aug 21 12:00 ET

Chongqing Pharscin Pharmaceutical: Announcement of Board of Directors' resolution for semi-annual report.

Aug 21 12:00 ET

Chongqing Pharscin Pharmaceutical: Summary of Half-Year Report in 2024.

Aug 21 12:00 ET

Chongqing Pharscin Pharmaceutical: Financial Report for the first half of 2024.

Aug 21 12:00 ET

Chongqing Pharscin Pharmaceutical: Half-year report for the year 2024.

Aug 21 12:00 ET

Chongqing Pharscin Pharmaceutical: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.

Aug 21 12:00 ET

Chongqing Pharscin Pharmaceutical: Announcement regarding the receipt of pharmaceutical re-registration approval notice.

Aug 6 12:00 ET

Chongqing Pharscin Pharmaceutical: Investor Relations Activity Record Form on July 24th, 2024

Jul 25 03:56 ET

Chongqing Pharscin Pharmaceutical: Announcement Regarding Completing Domestic Production Pharmaceutical Filing for the Product.

Jul 24 12:00 ET